South Africa’s Cannabis Master Plan: President Ramaphosa Wants to Lead Global Production

Can South Africa become the world’s next great cannabis production powerhouse?

South Africa’s cannabis master plan could reshape the global industry. In his 2025 State of the Nation Address, President Cyril Ramaphosa set out an unambiguous goal: “We want South Africa to lead in the commercial production of hemp and cannabis.” Those words carry enormous weight. Behind them sits a formal policy framework — the National Cannabis Master Plan — and a coordinated multi-department push to turn one of Africa’s most storied cannabis-producing nations into a regulated, export-oriented powerhouse. The stakes are significant: an estimated R28–36 billion market, more than 130,000 jobs targeted, and a potential seat at the top of the global supply chain.

What South Africa’s Cannabis Master Plan Actually Proposes

South Africa’s National Cannabis Master Plan is a government-developed policy framework designed to bring the country’s cannabis sector into the formal economy and position it for international commercial success. The plan is coordinated by the Department of Trade, Industry and Competition (the dtic), which is responsible for centralising policy, accelerating licensing, and building an inclusive commercial framework across the value chain.

The master plan addresses the full spectrum of the industry — from cultivation and processing to export and research — and involves four government departments working in parallel: the dtic, the Department of Agriculture Land Reform and Rural Development, the Department of Health, and the Department of Justice and Constitutional Development. This cross-departmental coordination reflects the ambition and complexity of what South Africa is attempting.

The Two-Track Policy Approach

The government is pursuing two parallel policy instruments. First, the Hemp and Cannabis Commercialisation Policy, expected to go before Cabinet for approval and public consultation by April 2026. This policy will outline the commercial development roadmap, balancing growth with public health and regulatory compliance. Second, an Overarching Cannabis Bill, scheduled for introduction in Parliament by mid-2027, which will consolidate all existing cannabis legislation — including the Cannabis for Private Purposes Act of 2024 — into a single unified legal framework.

A significant regulatory update that signals the seriousness of this agenda came in December 2025: South Africa revised its THC threshold for hemp plants from 0.2% to 2%, bringing it in line with more commercially viable international standards and making large-scale hemp farming substantially more attractive to producers and investors alike.

Production and Licensing Progress

As of early 2026, the government has already issued 1,408 cultivation permits through the Department of Agriculture, and SAHPRA — the South African Health Products Regulatory Authority — has granted approximately 120 licences for medical cannabis cultivation and export, with 93 licensed establishments active as of February 2025. These numbers are growing, but the master plan envisions a far larger and better-organised licensing ecosystem capable of supporting a globally competitive industry.

The Economic Case: Jobs, Exports, and GDP Impact

The economic argument for South Africa’s cannabis industry is compelling — and the government has made no secret of it. The current formal cannabis market is valued at approximately R14 billion, but with roughly half of all cannabis activity still operating in the illicit economy, the real market size is estimated at R28–36 billion. The National Cannabis Master Plan targets 10% annual growth as regulatory barriers come down and the industry expands into new commercial activities.

On employment, the sector already supports over 90,000 people — many in rural regions that have few other economic opportunities. The government’s formal target is 130,000 sustainable jobs, spanning cultivation, processing, manufacturing, research, and export logistics. For a country with an unemployment rate consistently above 30%, this potential is a major driver of political will.

Export ambitions are global in scope. The dtic is actively leveraging trade agreements — including the African Continental Free Trade Agreement (AfCFTA) — to help South African producers access markets across Africa, Asia, and the Middle East. Europe remains a key target as its medical cannabis market continues to expand. South Africa’s established horticultural infrastructure, combined with its climate advantages in the Western Cape and KwaZulu-Natal regions, gives it a structural edge that few other producing nations can match.

Current Regulatory Framework and What Must Change

South Africa’s cannabis legal landscape has evolved significantly over the past decade, though it remains fragmented — which is precisely what the master plan aims to fix. Understanding the current framework is essential for any operator evaluating market entry.

The key regulatory milestones:

• 2017: Medicinal cannabis legalised under the Medicines and Related Substances Act via SAHPRA licensing
• 2018: Constitutional Court rules that private use and home cultivation of cannabis are not criminal offences
• May 2024: Cannabis for Private Purposes Act (Act 7 of 2024) signed by President Ramaphosa, formally removing cannabis from the Drugs and Drug Trafficking Act
• December 2025: Hemp THC threshold raised from 0.2% to 2%, expanding commercial viability for farmers
• April 2026 target: Hemp and Cannabis Commercialisation Policy before Cabinet
• Mid-2027 target: Overarching Cannabis Bill introduced to Parliament

The critical gap is at the commercial layer. The Cannabis for Private Purposes Act decriminalises personal use and home cultivation but does not establish pathways for retail, commercial processing, or vertically integrated operations. The Overarching Cannabis Bill is meant to fill that void — but until it passes, the commercial framework remains incomplete.

The dual-authority structure also creates friction: SAHPRA regulates medical cannabis, while the Department of Agriculture holds authority over hemp cultivation permits. Consolidating these under a clearer, unified framework is one of the master plan’s core structural objectives.

Challenges: From Political Will to Infrastructure

The ambitions of South Africa’s cannabis master plan are real, but so are the obstacles. Operators and investors must weigh both sides clearly.

Regulatory Pace and Timeline Risk

Despite years of development, key commercial legislation has yet to reach Parliament. The April 2026 Cabinet submission for the Commercialisation Policy has been described as an “immediate priority” by the dtic — language that implicitly acknowledges prior timelines slipped. For companies planning market entry, this uncertainty is a genuine risk factor that needs to be built into investment timelines.

The Cannabis Food Ban Controversy

In early 2025, South Africa imposed a ban on cannabis in food products and ingestibles. The Democratic Alliance publicly warned that this decision threatened more than 1,800 businesses that had been operating in a grey zone producing CBD-infused foods and beverages. The ban illustrates that regulatory progress in South Africa is not linear — and that internal policy conflicts can actively undercut the master plan’s commercial objectives.

Infrastructure and Investment Gaps

South Africa’s climate and agricultural land are genuine competitive advantages. But GMP-certified processing facilities, cold-chain logistics, and pharmaceutical-grade manufacturing infrastructure are underdeveloped relative to the scale of ambition. Attracting the investment needed to close these gaps requires the clear, stable licensing pathways that the master plan promises but has not yet delivered.

The Illicit Market

With an estimated R14–22 billion still operating outside formal channels, the illicit market remains a formidable competitor to licensed operators. Regulation that is slow, expensive, or administratively burdensome will push producers to remain informal rather than paying to license up. The master plan’s inclusivity goals — targeting smallholder and rural farmers — add another layer of complexity to bringing informal operators into the fold.

What International Operators Should Know

For cannabis companies evaluating South Africa as a production hub, export source, or investment target, the picture is nuanced but strategically significant.

The opportunity is real. South Africa’s climate, its established agricultural expertise, its position within AfCFTA, and the highest-level political endorsement from President Ramaphosa make this a credible long-term play. The dtic’s active engagement in international trade missions and export market development signals that this is not performative policy — structural investment is happening.

But the commercial window has not yet opened. Full commercial licensing for vertically integrated cannabis operations — covering cultivation through processing, manufacturing, and retail — is not yet available. Operators looking to enter now should engage through the existing SAHPRA medical cannabis or Department of Agriculture hemp permit frameworks, and plan for full commercialisation legislation no earlier than 2027–2028.

Build compliance infrastructure now. Any company entering the South African market needs to be building its compliance systems before licensing is approved. SAHPRA’s requirements for licensed cultivators and exporters are detailed, and the forthcoming Overarching Cannabis Bill is expected to tighten — not loosen — documentation, traceability, and reporting standards. Implementing a robust cannabis compliance software platform before the licensing window opens positions operators to move immediately when approvals are granted, rather than scrambling to build systems under regulatory scrutiny.

Monitor the trade agreement pipeline. AfCFTA and the EU’s evolving pharmaceutical cannabis frameworks both present significant opportunities for South African exporters. Companies that establish GACP/GMP-compliant operations and documentation standards now will be first to benefit when bilateral trade agreements formalise preferential market access.

Frequently Asked Questions

What is South Africa’s cannabis master plan?

South Africa’s cannabis master plan is a formal government policy framework, coordinated by the Department of Trade, Industry and Competition (the dtic), that aims to formalise and grow the country’s hemp and cannabis industry. It covers licensing, cultivation, processing, export, and research, with the explicit goal of making South Africa a global leader in cannabis production. President Cyril Ramaphosa publicly endorsed the plan in his 2025 State of the Nation Address, stating: “We want South Africa to lead in the commercial production of hemp and cannabis.”

Is cannabis fully legal for commercial operations in South Africa?

Not yet. While medicinal cannabis has been legal since 2017 under SAHPRA licensing, and private use was decriminalised through the Cannabis for Private Purposes Act of 2024, a full commercial framework — covering retail, manufacturing, and vertically integrated operations — does not yet exist. The Hemp and Cannabis Commercialisation Policy is expected before Cabinet by April 2026, with an Overarching Cannabis Bill targeting Parliament by mid-2027. Full commercial licensing is realistically anticipated in 2027–2028.

When will South Africa’s cannabis commercial market fully open?

Based on current government timelines, the Hemp and Cannabis Commercialisation Policy is expected before Cabinet in April 2026, with public consultation to follow. The Overarching Cannabis Bill, which will create the full commercial licensing framework, is targeted for introduction to Parliament by mid-2027. Allowing for the legislative process, operators should plan for a realistic full commercial opening no earlier than 2027–2028. The December 2025 THC threshold increase and the ongoing SAHPRA licensing programme indicate that meaningful progress is happening in the interim.

Operating in South Africa’s Cannabis Market?

GrowerIQ provides seed-to-sale tracking and compliance tools built for SAHPRA requirements. When South Africa’s licensing window opens, be ready to move.

REQUEST DEMO